Cargando…

Smartphone measurements of physical activity and fitness are associated with early trial discontinuation of patients in (hemato)oncology phase I/II clinical trials

BACKGROUND: Patients, who discontinue early, do not benefit from phase I/II clinical trials (early-phase clinical trials (EPCT)). In this study, associations between objective smartphone measurements of physical activity and fitness and early trial discontinuation in patients with cancer participati...

Descripción completa

Detalles Bibliográficos
Autores principales: Douma, Joeri A. J., Zweegman, Sonja, Alberts, Mieke, Kruyswijk, Sandy, van de Donk, Niels C. W. J., van Linde, Myra, Buffart, Laurien M., Verheul, Henk M. W.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8163675/
https://www.ncbi.nlm.nih.gov/pubmed/33236210
http://dx.doi.org/10.1007/s00520-020-05902-2
_version_ 1783700951968776192
author Douma, Joeri A. J.
Zweegman, Sonja
Alberts, Mieke
Kruyswijk, Sandy
van de Donk, Niels C. W. J.
van Linde, Myra
Buffart, Laurien M.
Verheul, Henk M. W.
author_facet Douma, Joeri A. J.
Zweegman, Sonja
Alberts, Mieke
Kruyswijk, Sandy
van de Donk, Niels C. W. J.
van Linde, Myra
Buffart, Laurien M.
Verheul, Henk M. W.
author_sort Douma, Joeri A. J.
collection PubMed
description BACKGROUND: Patients, who discontinue early, do not benefit from phase I/II clinical trials (early-phase clinical trials (EPCT)). In this study, associations between objective smartphone measurements of physical activity and fitness and early trial discontinuation in patients with cancer participating in EPCT were investigated. METHODS: Before start of treatment, physical activity (steps/day) and physical fitness (meters walked in 6 min) were measured with a smartphone, and patient-reported physical function (PRO-PF) was assessed (EORTC QLQ-C30-PF). Early trial discontinuation was defined as discontinuation ≤ 28 days. Univariable logistic regression analyses were performed to study associations of physical activity, fitness, and function with early trial discontinuation. Optimal cutoff values of physical activity and fitness were assessed with ROCs, based on positive predictive values (PPV). RESULTS: Median (interquartile range (IQR)) step count was 4263 (2548–6897) steps/day, mean ± standard deviation 6-min walking distance was 477 ± 120 m and median (IQR) PRO-PF score was 83 (67–95) points. Fourteen patients (12%) discontinued the trial early. Smartphone measurements of physical activity in units of 100 steps per day (odds ratio (OR) = 0.96, 95% CI = 0.94–0.99, p = 0.01), physical fitness (OR = 0.99, 95% CI = 0.98–0.99, p < 0.01), and PRO-PF (OR = 0.97, 95% CI = 0.94–1.00, p = 0.03) were associated with early trial discontinuation. Optimal cutoff values were < 900 steps for physical activity and < 285 m for physical fitness. PPV for early trial discontinuation was 100% in patients who walked both < 1500 steps per day and < 300 m in 6 min. CONCLUSIONS: Objective smartphone measurements of physical activity and fitness are associated with early trial discontinuation. However, cutoff values should be externally validated in a larger cohort before implementation in clinical practice.
format Online
Article
Text
id pubmed-8163675
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Springer Berlin Heidelberg
record_format MEDLINE/PubMed
spelling pubmed-81636752021-06-17 Smartphone measurements of physical activity and fitness are associated with early trial discontinuation of patients in (hemato)oncology phase I/II clinical trials Douma, Joeri A. J. Zweegman, Sonja Alberts, Mieke Kruyswijk, Sandy van de Donk, Niels C. W. J. van Linde, Myra Buffart, Laurien M. Verheul, Henk M. W. Support Care Cancer Original Article BACKGROUND: Patients, who discontinue early, do not benefit from phase I/II clinical trials (early-phase clinical trials (EPCT)). In this study, associations between objective smartphone measurements of physical activity and fitness and early trial discontinuation in patients with cancer participating in EPCT were investigated. METHODS: Before start of treatment, physical activity (steps/day) and physical fitness (meters walked in 6 min) were measured with a smartphone, and patient-reported physical function (PRO-PF) was assessed (EORTC QLQ-C30-PF). Early trial discontinuation was defined as discontinuation ≤ 28 days. Univariable logistic regression analyses were performed to study associations of physical activity, fitness, and function with early trial discontinuation. Optimal cutoff values of physical activity and fitness were assessed with ROCs, based on positive predictive values (PPV). RESULTS: Median (interquartile range (IQR)) step count was 4263 (2548–6897) steps/day, mean ± standard deviation 6-min walking distance was 477 ± 120 m and median (IQR) PRO-PF score was 83 (67–95) points. Fourteen patients (12%) discontinued the trial early. Smartphone measurements of physical activity in units of 100 steps per day (odds ratio (OR) = 0.96, 95% CI = 0.94–0.99, p = 0.01), physical fitness (OR = 0.99, 95% CI = 0.98–0.99, p < 0.01), and PRO-PF (OR = 0.97, 95% CI = 0.94–1.00, p = 0.03) were associated with early trial discontinuation. Optimal cutoff values were < 900 steps for physical activity and < 285 m for physical fitness. PPV for early trial discontinuation was 100% in patients who walked both < 1500 steps per day and < 300 m in 6 min. CONCLUSIONS: Objective smartphone measurements of physical activity and fitness are associated with early trial discontinuation. However, cutoff values should be externally validated in a larger cohort before implementation in clinical practice. Springer Berlin Heidelberg 2020-11-24 2021 /pmc/articles/PMC8163675/ /pubmed/33236210 http://dx.doi.org/10.1007/s00520-020-05902-2 Text en © The Author(s) 2020 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) .
spellingShingle Original Article
Douma, Joeri A. J.
Zweegman, Sonja
Alberts, Mieke
Kruyswijk, Sandy
van de Donk, Niels C. W. J.
van Linde, Myra
Buffart, Laurien M.
Verheul, Henk M. W.
Smartphone measurements of physical activity and fitness are associated with early trial discontinuation of patients in (hemato)oncology phase I/II clinical trials
title Smartphone measurements of physical activity and fitness are associated with early trial discontinuation of patients in (hemato)oncology phase I/II clinical trials
title_full Smartphone measurements of physical activity and fitness are associated with early trial discontinuation of patients in (hemato)oncology phase I/II clinical trials
title_fullStr Smartphone measurements of physical activity and fitness are associated with early trial discontinuation of patients in (hemato)oncology phase I/II clinical trials
title_full_unstemmed Smartphone measurements of physical activity and fitness are associated with early trial discontinuation of patients in (hemato)oncology phase I/II clinical trials
title_short Smartphone measurements of physical activity and fitness are associated with early trial discontinuation of patients in (hemato)oncology phase I/II clinical trials
title_sort smartphone measurements of physical activity and fitness are associated with early trial discontinuation of patients in (hemato)oncology phase i/ii clinical trials
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8163675/
https://www.ncbi.nlm.nih.gov/pubmed/33236210
http://dx.doi.org/10.1007/s00520-020-05902-2
work_keys_str_mv AT doumajoeriaj smartphonemeasurementsofphysicalactivityandfitnessareassociatedwithearlytrialdiscontinuationofpatientsinhematooncologyphaseiiiclinicaltrials
AT zweegmansonja smartphonemeasurementsofphysicalactivityandfitnessareassociatedwithearlytrialdiscontinuationofpatientsinhematooncologyphaseiiiclinicaltrials
AT albertsmieke smartphonemeasurementsofphysicalactivityandfitnessareassociatedwithearlytrialdiscontinuationofpatientsinhematooncologyphaseiiiclinicaltrials
AT kruyswijksandy smartphonemeasurementsofphysicalactivityandfitnessareassociatedwithearlytrialdiscontinuationofpatientsinhematooncologyphaseiiiclinicaltrials
AT vandedonknielscwj smartphonemeasurementsofphysicalactivityandfitnessareassociatedwithearlytrialdiscontinuationofpatientsinhematooncologyphaseiiiclinicaltrials
AT vanlindemyra smartphonemeasurementsofphysicalactivityandfitnessareassociatedwithearlytrialdiscontinuationofpatientsinhematooncologyphaseiiiclinicaltrials
AT buffartlaurienm smartphonemeasurementsofphysicalactivityandfitnessareassociatedwithearlytrialdiscontinuationofpatientsinhematooncologyphaseiiiclinicaltrials
AT verheulhenkmw smartphonemeasurementsofphysicalactivityandfitnessareassociatedwithearlytrialdiscontinuationofpatientsinhematooncologyphaseiiiclinicaltrials